Endometrial receptivity array: Clinical application

Abstract

Human implantation is a complex process requiring synchrony between a healthy embryo and a functionally competent or receptive endometrium. Diagnosis of endometrial receptivity (ER) has posed a challenge and so far most available tests have been subjective and lack accuracy and a predictive value. Microarray technology has allowed identification of the transcriptomic signature of the window of receptivity window of implantation (WOI). This technology has led to the development of a molecular diagnostic tool, the ER array (ERA) for diagnosis of ER. Use of this test in patients with recurrent implantation failure (RIF) has shown that the WOI is displaced in a quarter of these patients and use of a personalized embryo transfer (pET) on the day designated by ERA improves reproductive performance. Our results in the Indian population revealed an endometrial factor in 27.5% RIF patients, which was significantly greater than the non-RIF group 15% (P = 0.04). After pET, the overall ongoing pregnancy rate was 42.4% and implantation rate was 33%, which was at par with our in-vitro fertilization results over 1-year. We also performed ERA in patients with persistently thin endometrium, and it was reassuring to find that the endometrium in 75% of these patients was receptive despite being 6 mm or less. A pregnancy rate of 66.7% was achieved in this group. Though larger studies are required to validate these results ERA has become a useful tool in our diagnostic armamentarium for ER.

Endometrial microbes and microbiome: Recent insights on the inflammatory and immune “players” of the human endometrium

“…Also, an endometrial receptivity array (ERA test) has been recently introduced . This assay classifies the endometrium as receptive, pre‐receptive, or post‐receptive based on specific transcriptomic signature regardless of its histological appearance . Unfortunately, each of the above reported technique shows limitations: invasive procedures, expertise dependency, sample collection, and culturing limitations.…”

Effect of Low‐Dose Aspirin on Midluteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss

“…An unsupportive endometrium, leading to abnormal implantation, is considered a vital factor contributing to recurrent pregnancy loss 2 . There is general agreement that the impedance to uterine artery blood flow diminishes progressively and reaches the lowest values during the midluteal phase, which temporally coincides with the implantation window 3 .…”

Assisted reproductive technology in reproductive medicine — possibilities and limitations

“…Still, the research continues to develop a test based on a single molecular marker. The list of potential candidates is long, based on temporary expression of many proteins during the implantation window [37,38].…”